Dr Harvey Pass speaks about a novel biomarker test that is believed to be the most accurate yet in detecting proteins secreted from tumours caused by exposure to asbestos. In a blinded test the proteomic assay could detect 15 of 19 cases of malignant pleural mesothelioma that were in stage 1 or stage 2, making the test about 80 percent sensitive, a measure of how accurately a test can identify disease. In addition, the specificity of the test was 100 percent, meaning there were no false positives in this study. To view the slides click here.